The global ACE Inhibitors market garnered revenue around USD XX Billion in 2019 and projected to reach USD 7 Billion in 2027, with at a compound annual growth rate of 3.14% throughout the estimate period from 2020 to 2027.
ACE inhibitors are a common choice of medications used to control high blood pressure. Benazepril, captopril, enalapril, cilazapril, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, and trandolapril are some of the ACE inhibitors used for treating hypertension. The prescribing rate of different types of ACE inhibitors varies according to the country. For instance, in New Zealand, about 60% of the people taking angiotensin-converting enzyme (ACE) inhibitors are prescribed cilazapril, whereas, in the UK and Australia, cilazapril is less frequently used.
The growing adoption of ACE Inhibitors in the management of chronic disorders is expected to drive the market growth. In the hypertensive drugs segment, ACE Inhibitors are commonly used products after diuretics.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the ACE Inhibitors market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the ACE Inhibitors market growth.
The global ACE Inhibitors market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Bristol-Myers Squibb Company
Par Pharmaceutical Companies, Inc.
UCB, Inc.
Pfizer, Inc.
AbbVie Inc.
AstraZeneca
Bausch Health Companies, Inc.
Novartis AG
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Silvergate Pharmaceuticals, Inc.
Others
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
By Drug
Lisinopril:
Enalapril:.
Ramipril:.
Benazepril:
Fosinopril:
Captopril:
Moexipril:
Others
By Application
Heart Failure:
Hypertension:
Diabetes:
Heart Attack
Chronic Kidney Disease
Others
By Dosage Form
Oral Tablets:
Oral Solution:
By Distribution Channel
Retail Pharmacy:
Hospital Pharmacy:
E-commerce Websites and Online Drug Stores:
Others:
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization